ARNIMAX Penetrating Pain Relief Gel

openFDA label record#

This page contains supplementary openFDA label data. For the canonical label presentation, use the corresponding DailyMed Structured Product Label.

Verified complete openFDA source JSON (canonical bytes are SHA-256 checked before publication)

Brand name: ARNIMAX Penetrating Pain Relief Gel
Generic name: MENTHOL
Manufacturer: WYNNPHARM INC.
Product type: HUMAN OTC DRUG
SPL set ID: 3a31f805-19c6-4036-a663-ebef9b212007
SPL ID: 09d7163b-7e66-1473-e063-6294a90a81a1
Version: 2
Effective date: 2023-11-10
Source export date: 2026-10-12
Source partition: 3
Source file: https://download.open.fda.gov/drug/label/drug-label-0003-of-0014.json.zip
Source object key: raw/openfda/drug-label/2026-10-12/f40eac55ff4c5d55c3d8bbc5766ea7e21e4196960cfb4703b96a406b491c0cd5/drug-label-0003-of-0014.json.zip
Source manifest SHA-256: 7e6b178df8f32cac9a78e0f5d09c588344509b04fe41effb1dde9102e2a45be6
Import run: 20261013T011858Z
Imported at: 2026-10-13 01:30:50

Harmonized routes table
Harmonized routes
TOPICAL

Harmonized identifier links#

Every typed identifier imported from the complete openFDA harmonization object is paginated here; values are not reduced to a first match.

Harmonized identifiers page 1 of 1 · 11 matching rows.

Type, Scope, Identifier table
Type	Scope	Identifier	Source field
application number		M017	openfda.application_number
brand name		ARNIMAX Penetrating Pain Relief Gel	openfda.brand_name
generic name		MENTHOL	openfda.generic_name
manufacturer name		WYNNPHARM INC.	openfda.manufacturer_name
ndc	package	35324-274-00	openfda.package_ndc
ndc	product	35324-274	openfda.product_ndc
ndc11	package	35324027400	derived:openfda.package_ndc
rxcui		259150	openfda.rxcui
spl id		09d7163b-7e66-1473-e063-6294a90a81a1	id
spl set id		3a31f805-19c6-4036-a663-ebef9b212007	set_id
unii		L7T10EIP3A	openfda.unii

Warnings cross-check#

openFDA text is shown for search and cross-checking; DailyMed SPL is canonical.

Warnings sections page 1 of 1 · 1 matching rows.

warnings

Warning For external use only. Do not use if allergic to any ingredients listed in this product. When using this product • Use only as direcred • Avoid contact with eyes and mucous membranes • Do not apply directly to wounds or broken skin • Do not bandage tightly or use a heating pad. Stop use and ask a doctor if • Condition worsens • Condition persists for more than 7 days or clears up and occurs again within a few days. If pregnant or breastfeeding, ask a health professional before use. Keep out of reach of children. If swallowed, seek medical attention or contact a Poison Control Center right away.

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.